Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction
NCT00712101
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1912
Enrollment
OTHER
Sponsor class
Conditions
ST-elevation Myocardial Infarction
Interventions
DRUG:
abciximab intracoronary
DRUG:
abciximab intravenously
Sponsor
University of Leipzig